Scientists use iPS cells to study rare neurological disease

08/20/2009 | MIT Technology Review

U.S. scientists are studying the mechanisms of a rare neurological disorder, called familial dysautonomia, with the aid of induced pluripotent stem cells -- in this case, derived from the reprogrammed skin cells of patients with the disease. They also are using the iPS cells to test the effectiveness of several drug candidates on the rare condition.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX